Company: IMNN
Filing Date: 2025-05-13
Form Type: 8-K
Source: 0001641172-25-009775
Chunk: 1

Company: Imunon, Inc.
Filing Date: 2025-05-13
Form: 8-K
Item: Item 3.02
Chunk 1
---
Item 3.02

Unregistered Sales of Equity Securities

The
information set forth in Item 1.01 of this Current Report on Form 8-K pertaining to the Warrant Exchange is incorporated by reference
into this Item 3.02. The Warrant Exchange will be completed, and the Warrant Exchange Shares will be issued in reliance on, the exemption
from registration provided by Section 3(a)(9) of the Securities Act, on the basis that (a) the Warrant Exchange Shares are being issued
in exchange for other outstanding securities of the Company; (b) there will be no additional consideration delivered by the Warrant Holders
in connection with the Warrant Exchange; and (c) there were no commissions or other remuneration paid by the Company in connection with
the Warrant Exchange.

Item 9.01 Financial Statements and Exhibits